TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CLEO Diagnostics Ltd ( (AU:COV) ) just unveiled an announcement.
Cleo Diagnostics Ltd announced the release of 46,900,000 fully paid ordinary shares from escrow, effective 22 August 2025. This action, authorized by the Board, does not alter the company’s issued capital and reflects compliance with ASX Listing Rule 3.10A, potentially impacting shareholder dynamics and market perception.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Ltd operates in the medical diagnostics industry, focusing on developing and providing diagnostic solutions. The company is listed on the Australian Securities Exchange under the ticker COV.
Average Trading Volume: 71,101
Technical Sentiment Signal: Buy
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.